Article of the Year

Which Publication Will Have the Most Impact on Neonatal Care?

Help Select the 2023 EBNEO Impact Article of the Year!

Each year, there are thousands of new contributions to the neonatal literature. Few change practice. Which 2023 publication will have the most impact on neonatal care? Review the nominees in the links below and make your selections by voting on our website. Choose the two finalists on 12/29/24 and the most impactful publication on 12/31/24!

Select the Most Impactful Article of 2023

Which 2023 publication will have the most impact on neonatal care?

Submit one vote for your choice. Multiple votes will be monitored and removed. Follow the links below to each publication.

This poll is no longer accepting votes

Which 2023 publication will have the most impact on neonatal care? Follow each link to the article!

Select the Finalists 

Which 2023 publications will have the most impact on neonatal care?

Select the TWO finalists. Please vote for two articles, once. Multiple votes will be monitored and removed. Follow the links below to each publication.

This poll is no longer accepting votes

Which 2023 publication will have the most impact on neonatal care? Follow each link to the article!

Review the 2023 Nominees

In alphabetical order:

Hansen et al. Cerebral Oximetry Monitoring in Extremely Preterm Infants. NEJM. 2023;388:1501-1511

Kampmann et al. Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. NEJM. 2023;388:1451-1464

Katheria et al. Umbilical Cord Milking Versus Delayed Cord Clamping in Infants 28 to 32 Weeks: A Randomized Trial – Pediatrics. 2023;152 (6): e2023063113

Kidman et al. Higher versus lower nasal continuous positive airway pressure for extubation of extremely preterm infants in Australia (ÉCLAT): a multicentre, randomised, superiority trial – Lancet Child Adol. 2023; 7(12): 844 – 851

Marshall et al. Assessment of infant position and timing of stylet removal to improve lumbar puncture success in neonates (NeoCLEAR): an open-label, 2 × 2 factorial, randomised, controlled trial – Lancet Child Adol. 2023;7(2): 91 – 100

Moore et al. Two-year outcomes following a randomised platelet transfusion trial in preterm infants – ADC F&N.

Salas et al. Early Human Milk Fortification in Infants Born Extremely Preterm: A Randomized Trial – Pediatrics. 2023; 152 (3): e2023061603

Young et al. Eat, Sleep, Console Approach or Usual Care for Neonatal Opioid Withdrawal – NEJM. 2023;388:2326-2337

Past Results

The 2022 EBNEO Impact Article of the Year

EBNEO.AOTY_1_03_24

Bloomfield FH, Jiang Y, Harding JE, et al. Early Amino Acids in Extremely Preterm Infants and Neurodisability at 2 Years. NEJM. 2022; 387:1661-1672.

Hammitt LL, Dagan R, Yuan Y, et al. Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants. NEJM. 2022; 386:837-846.

Hodgson KA, Owen LS, Kamlin OF, et al. Nasal High-Flow Therapy during Neonatal Endotracheal Intubation. NEJM. 2022; 386:1627-1637.

Hundscheid T, Onland W, Kooi EMW, et al. Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus. NEJM. 2023; 388:980-990

Gallup JA, Ndakor SM, Pazzano C, et al. Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in neonates born preterm. J Pediatr. 2023; 254:17-24

Watterberg KL, Walsh MC, Chawla S, et al. Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia. NEJM. 2022; 386:1121-1131

WHO ACTION Collaborators. Antenatal dexamethasone for late preterm birth: A multi-centre, two-arm, parallel, double-blind, placebo-controlled, randomized trial. eClinicalMedicine. 2022; 44:101285

Wu YW, Comstock BA, Gonzalez FF, et al. Trial of Erythropoietin for Hypoxic–Ischemic Encephalopathy in Newborns. NEJM. 2022; 387:148-159

The 2021 EBNEO Impact Article of the Year

EBNEO.AOTY21.12.15

 

 

css.php